Pfizer Strata Oncology, Pfizer Partner to Explore New Biomarker Indications for FDA-Approved Drugs Pfizer is the first drugmaker to join the Strata PATH platform trial and will contribute drugs to advanced cancer patients in four study arms. Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients. UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects Led by a group of 10 biopharmaceutical firms, the project will use Olink's proteomic technology to look at participants' plasma levels of roughly 1,500 proteins. Opko Health Q3 Revenues Up 87 Percent The firm's subsidiary BioReference Laboratories performed 3.5 million COVID-19 PCR tests and 300,000 serology tests during the quarter. Roche EGFR Mutation Test Approved by FDA as Companion Diagnostic for NSCLC Roche's real-time PCR test detects defined mutations of the epidermal growth factor receptor gene in DNA from non-small cell lung cancer patients. Nov 13, 2019 Pfizer Inks Deal for Access to Centogene Rare Disease Data Sep 23, 2019 Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium Jul 23, 2019 Pfizer, Syapse Ink Real-World Precision Oncology Collaboration Jun 6, 2019 TAPUR Study Investigators Report First Positive Findings, Pursuing Tissue-Agnostic Cohorts Premium Jun 4, 2019 At ASCO, Real-World Data Shows Potential to Improve Precision Oncology Premium Apr 30, 2019 Exact Sciences Q1 Revenues Up 79 Percent Jan 16, 2019 Qiagen EGFR Assay Approved in Japan as CDx to Pfizer NSCLC Drug Oct 30, 2018 Exact Sciences Q3 Revenues Up 63 Percent Oct 30, 2018 Precision Oncology Highlights From ESMO 2018 Oct 16, 2018 FDA Approves Myriad Genetics BRCA CDx With Pfizer's Metastatic Breast Cancer Drug Oct 12, 2018 AmoyDx Lung Cancer CDx Approved in South Korea Oct 10, 2018 Myriad Upgraded to Overweight by Piper Jaffray; Signs Lab Service Deal with Pfizer Aug 22, 2018 Exact Sciences, Pfizer to Comarket Cologuard Jun 18, 2018 Myriad Genetics Submits Supplementary PMA for BRACAnalysis CDx May 21, 2018 Pfizer to Offer $1.5M in Grant Funding to Support BRCA Testing Apr 11, 2018 Pfizer, Oxford BioDynamics, U of Glasgow Researchers Develop Approach to Gauge Response to RA Drug Premium Feb 6, 2018 Quest to Offer Thermo Fisher's Oncomine Dx Target Test Jan 30, 2018 NIH Launches Parkinson's Disease Research Partnership Jan 16, 2018 Pfizer, Foundation Medicine Developing Companion Diagnostics for Cancer Drugs Jan 8, 2018 Regeneron Partners With AbbVie, Alnylam, AstraZeneca, Biogen, Pfizer to Sequence UK Biobank Samples Load More Breaking News MicroGenDx Acquires Sequencing Lab RTL Genomics Pacific Biosciences, Rady Children's Collaborate on Study of WGS-Based Rare Disease Dx Codex DNA Closes $122.7M IPO Infinity BiologiX to Offer Cytox Alzheimer's Disease Genetic Risk Test in US Archaic Hominin History, Interactions Revealed With Denisova Cave Sediment Sequences Liquid Biopsy Startup Adela Launches With $60M Series A Financing Round The Scan NFTs for Genome Sharing Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data. Wastewater Warning System Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19. Networks to Boost Surveillance Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance. Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.